NCT04751773

Brief Summary

Surgery is a primary treatment modality in the intended curative treatment of colorectal liver metastases (CRLM). However, surgery elicits a cascade of potentially detrimental stress responses that may drive the onset of long-term disease progression. Exercise training is emerging as an adjunct treatment in surgical oncology and holds potential to modify the surgical stress response. Against this background, we designed the present randomized controlled trial to evaluate the therapeutic role of pre- and postoperative exercise training in patients with CRLM undergoing open liver resection.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 12, 2021

Completed
28 days until next milestone

Study Start

First participant enrolled

March 12, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

2.5 years

First QC Date

January 29, 2021

Last Update Submit

November 16, 2023

Conditions

Keywords

Aerobic exerciseResistance exercisePerioperative medicinePrehabilitationRehabilitationCancerSurgical oncologySurgeryExercise oncology

Outcome Measures

Primary Outcomes (1)

  • Serious adverse events

    From discharge to 8 weeks after discharge

Secondary Outcomes (17)

  • Postoperative hospital admissions

    From discharge to 8 weeks after discharge

  • Relative dose intensity (RDI) of adjuvant chemotherapy

    From date of planned initiation of adjuvant chemotherapy until 8 weeks after discharge

  • Time to initiation of adjuvant chemotherapy

    From surgery until 8 weeks after discharge

  • Patient-reported symptomatic adverse events

    Baseline, 7 days after discharge, 7 days after each administration of adjuvant chemotherapy, 8 weeks after discharge.

  • Surgical stress: IL-1β

    Baseline, after last incision, after resection, 3 hour post-surgery, postoperative day 1, postoperative day 3, postoperative day 15, 8 weeks after discharge

  • +12 more secondary outcomes

Other Outcomes (75)

  • 3-years cancer-specific survival

    Randomization to 3 years after randomization

  • 3-years overall survival

    Randomization to 3 years after randomization

  • Carcinoembryonic antigen (CEA)

    Baseline, postoperative day 15, 8 weeks after discharge

  • +72 more other outcomes

Study Arms (2)

Standard care alone (CON)

NO INTERVENTION

Participants allocated to CON receive the standard patient care program, as provided by Rigshospitalet, Copenhagen, Denmark. Participants allocated to CON are allowed to exercise on their own initiative or participate in any standard care hospital- or municipality-based exercise training program.

Postoperative exercise training and standard care (EX)

EXPERIMENTAL

Participants allocated to EX receive the standard patient care program, as provided by Rigshospitalet, Copenhagen, Denmark, and postoperative exercise training. The postoperative exercise training program consists of 8 weeks of supervised and home-based exercise 5 times/week. The intensity and duration are progressively increased during the postoperative period

Behavioral: Exercise training

Interventions

Perioperative exercise training

Postoperative exercise training and standard care (EX)

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Age \<18
  • Pregnancy
  • Other known malignancy requiring active cancer treatment that prohibits execution of test or training procedures
  • Conditions that prohibit execution of trial procedures
  • Inability to understand the Danish language.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet

Copenhagen, Denmark

Location

Related Publications (1)

  • Thomsen SN, Krabek R, Yfanti C, Sjoberg S, Sundberg A, Dalsgaard DM, Thomsen LM, Aasvang EK, Qvortrup C, Mau-Sorensen M, Pedersen BK, Larsen PN, Sillesen MH, Schultz NA, Christensen JF, Simonsen C. Postoperative Exercise Training in Patients with Colorectal Liver Metastases A Randomized Controlled Trial. Ann Surg. 2024 Nov 11. doi: 10.1097/SLA.0000000000006587. Online ahead of print.

MeSH Terms

Conditions

Neoplasms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jesper F Christensen, PhD

    Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The participants and the exercise intervention instructors cannot be blinded, given the nature of the intervention. The outcome assessors of the primary and key secondary outcomes (adverse events and markers of surgical stress, respectively) will be blinded. For practical reasons, the outcome assessors of the following secondary outcomes will be not be blinded: resting cardiovascular factors, aerobic capacity, muscle strength, functional performance, and body composition and anthropometrics.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 29, 2021

First Posted

February 12, 2021

Study Start

March 12, 2021

Primary Completion

September 1, 2023

Study Completion

March 1, 2026

Last Updated

November 18, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations